Norcliffe Capital partners with high net worth investors to back cutting edge medical technologies, with a model built on deep engagement rather than passive capital. We focus on UK life sciences, where breakthrough science and commercial potential converge, and where close, consistent support can materially influence outcomes.

Our approach is deliberately hands on. We work side by side with founders and management teams, helping shape strategy, preparing for technical and regulatory milestones, supporting commercial planning, and opening doors across our network of investors, clinicians, and industry leaders. This level of involvement allows us to identify risks early, strengthen execution, and accelerate progress toward scale.

We believe strong relationships are central to value creation. Our investors benefit from transparent communication, disciplined judgement, and access to opportunities grounded in rigorous assessment. Our portfolio companies benefit from a committed partner who stays engaged throughout their journey, not just at the point of investment.

“Profit with Purpose” underpins everything we do: supporting innovations that can improve patient outcomes while delivering attractive, long term returns.

Your capital is at risk.

Norcliffe Capital Ltd (FRN #826977) is an Appointed Representative of Sturgeon Ventures LLP, which is authorised and regulated by the Financial Conduct Authority (FRN #452811).

Norcliffe Capital Limited

Org chart

Teams

Offices